Cerus (CERS) Cash from Financing Activities (2010 - 2026)
Cerus' (CERS) quarterly Cash from Financing Activities came in at -$20.0 million in Q2 2026, down 15434.11% year-over-year from N/an in Q2 2025, and down 1781.12% quarter-over-quarter from $1.2 million in Q1 2026.
Analysis
Cerus (CERS) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Cerus has disclosed Cash from Financing Activities across 17 years of filings, most recently posting -$20.0 million for Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 15434.11% year-over-year to -$20.0 million; the TTM figure through Jun 2026 stood at -$19.6 million (down 1218.88% YoY), while the FY2025 annual figure was $231000.0, down 95.35% from the prior year.
- Cash from Financing Activities came in at -$20.0 million for Q2 2026 at Cerus, down from $1.2 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $7.6 million in Q3 2023 to a low of -$20.0 million in Q2 2026.
- Average Cash from Financing Activities over 5 years is $67388.9, with a median of $601500.0 recorded in 2022.
- Year-over-year, Cash from Financing Activities surged 601.29% in 2023 and plunged 15434.11% in 2026.
- Over 5 years, Cash from Financing Activities stood at $457000.0 in 2022, then soared by 158.86% to $1.2 million in 2023, then sank by 36.94% to $746000.0 in 2024, then slumped by 238.2% to -$1.0 million in 2025, then tumbled by 1843.65% to -$20.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$20.0 million in Q2 2026, $1.2 million in Q1 2026, and -$1.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Cerus | 504.42 Mn | 448.16 Mn | 29.53 Mn | -20.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20.04 Mn |
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | 320,000.00 |
| Jun 30, 2025 | -129,000.00 |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 746,000.00 |
| Sep 30, 2024 | 60,000.00 |
| Jun 30, 2024 | -1.40 Mn |
| Mar 31, 2024 | 5.56 Mn |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | 7.60 Mn |
| Jun 30, 2023 | -173,000.00 |
| Mar 31, 2023 | 2.06 Mn |
| Dec 31, 2022 | 457,000.00 |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 202,000.00 |
| Mar 31, 2022 | 2.45 Mn |
| Dec 31, 2021 | 12.10 Mn |
| Sep 30, 2021 | 4.58 Mn |